PubRank

K Lamborn

Author PubWeight™ 30.40‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Gamma knife for glioma: selection factors and survival. Int J Radiat Oncol Biol Phys 1996 1.56
2 Treatment of pediatric low-grade gliomas with a nitrosourea-based multiagent chemotherapy regimen. J Neurooncol 1997 1.47
3 The treatment of brain stem and thalamic gliomas with 78 Gy of hyperfractionated radiation therapy. Int J Radiat Oncol Biol Phys 1995 1.45
4 Medulloblastoma in adults. Int J Radiat Oncol Biol Phys 1995 1.38
5 A multi-institutional retrospective study of intracranial ependymoma in children: identification of risk factors. J Pediatr Hematol Oncol 1999 1.16
6 Chromosomal abnormalities subdivide ependymal tumors into clinically relevant groups. Am J Pathol 2001 1.07
7 Annexin II marks astrocytic brain tumors of high histologic grade. Oncol Res 1994 1.06
8 Pretreatment with protease is a useful experimental strategy for enhancing adenovirus-mediated cancer gene therapy. Hum Gene Ther 2000 1.04
9 Genetic analysis of glioblastoma multiforme provides evidence for subgroups within the grade. Genes Chromosomes Cancer 1998 1.01
10 Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme. Int J Radiat Oncol Biol Phys 2001 1.00
11 Highly anaplastic astrocytoma: a review of 357 patients treated between 1977 and 1989. Int J Radiat Oncol Biol Phys 1992 0.97
12 Influence of a child's sex on medulloblastoma outcome. JAMA 1998 0.96
13 Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 1998 0.92
14 A statistical approach for analyzing clonogenic survival data. Radiat Res 1996 0.92
15 Phase II study of paclitaxel in patients with recurrent malignant glioma. J Clin Oncol 1996 0.91
16 Chromosomal abnormalities in glioblastoma multiforme by comparative genomic hybridization: correlation with radiation treatment outcome. Clin Cancer Res 1999 0.87
17 Radiotherapy-associated neutropenia and thrombocytopenia: analysis of risk factors and development of a predictive model. Blood 1997 0.87
18 Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors. Int J Radiat Oncol Biol Phys 1998 0.84
19 A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas. Neurosurgery 2000 0.84
20 GM-CSF accelerates neutrophil recovery after autologous hematopoietic stem cell transplantation. Bone Marrow Transplant 1996 0.82
21 Natural history of anal cytologic abnormalities and papillomavirus infection among homosexual men with group IV HIV disease. J Acquir Immune Defic Syndr 1992 0.82
22 Image-guided robotic stereotactic body radiotherapy for benign spinal tumors: theUniversity of California San Francisco preliminary experience. Technol Cancer Res Treat 2007 0.81
23 Hyperfractionated craniospinal radiation therapy for primitive neuroectodermal tumors: results of a Phase II study. Int J Radiat Oncol Biol Phys 1999 0.81
24 Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy. Pediatr Neurosurg 1996 0.81
25 Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas. Int J Radiat Oncol Biol Phys 1995 0.80
26 Prognostic significance of the proliferative potential of intracranial gliomas measured by bromodeoxyuridine labeling. Int J Cancer 1993 0.80
27 Multiple genetic aberrations including evidence of chromosome 11q13 rearrangement detected in pituitary adenomas by comparative genomic hybridization. J Neurosurg 1999 0.80
28 Modification of radiation-induced brain injury by alpha-difluoromethylornithine. Radiat Res 1991 0.79
29 Proliferative potential and prognostic evaluation of low-grade astrocytomas. J Neurooncol 1994 0.79
30 Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children. Neuro Oncol 2000 0.78
31 Measurement of radiation-induced damage in human glioma cells with flow cytometry. Cancer Res 1996 0.77
32 Proliferation markers in gliomas: a comparison of BUDR, KI-67, and MIB-1. J Neurooncol 1995 0.76